Cohen Klingenstein’s Gilead Sciences GILD Stock Holding History

Cohen Klingenstein’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.62M	Hold	20,700	–	–	0.07%	108
2026 Q1	$2.88M	Hold	20,700	–	–	0.09%	96
2025 Q4	$2.54M	Hold	20,700	–	–	0.08%	106
2025 Q3	$2.3M	Hold	20,700	–	–	0.07%	109
2025 Q2	$2.3M	Hold	20,700	–	–	0.08%	112
2025 Q1	$2.32M	Hold	20,700	–	–	0.08%	109
2024 Q4	$1.91M	Sell	20,700 -15,000	-42%	-$1.35M	0.07%	118
2024 Q3	$2.99M	Hold	35,700	–	–	0.1%	104
2024 Q2	$2.45M	Hold	35,700	–	–	0.09%	112
2024 Q1	$2.62M	Hold	35,700	–	–	0.1%	109
2023 Q4	$2.89M	Hold	35,700	–	–	0.12%	99
2023 Q3	$2.68M	Hold	35,700	–	–	0.12%	98
2023 Q2	$2.75M	Hold	35,700	–	–	0.12%	102
2023 Q1	$2.96M	Hold	35,700	–	–	0.14%	99
2022 Q4	$3.06M	Hold	35,700	–	–	0.15%	94
2022 Q3	$2.2M	Hold	35,700	–	–	0.12%	102
2022 Q2	$2.21M	Hold	35,700	–	–	0.11%	104
2022 Q1	$2.12M	Hold	35,700	–	–	0.09%	121
2021 Q4	$2.59M	Sell	35,700 -3,742	-9%	-$258K	0.1%	110
2021 Q3	$2.75M	Sell	39,442 -4,742	-11%	-$333K	0.12%	112
2021 Q2	$3.04M	Hold	44,184	–	–	0.13%	111
2021 Q1	$2.86M	Hold	44,184	–	–	0.13%	112
2020 Q4	$2.57M	Hold	44,184	–	–	0.13%	110
2020 Q3	$2.79M	Hold	44,184	–	–	0.16%	103
2020 Q2	$3.4M	Hold	44,184	–	–	0.21%	85
2020 Q1	$3.3M	Hold	44,184	–	–	0.24%	80
2019 Q4	$2.87M	Hold	44,184	–	–	0.17%	103
2019 Q3	$2.8M	Buy	44,184 +15,000	+51%	+$981K	0.18%	102
2019 Q2	$1.97M	Buy	29,184 +16,000	+121%	+$1.05M	0.14%	108
2019 Q1	$857K	Hold	13,184	–	–	0.06%	124
2018 Q4	$825K	Hold	13,184	–	–	0.12%	98
2018 Q3	$1.02M	Hold	13,184	–	–	0.13%	98
2018 Q2	$934K	Hold	13,184	–	–	0.13%	100
2018 Q1	$994K	Hold	13,184	–	–	0.14%	97
2017 Q4	$945K	Hold	13,184	–	–	0.13%	101
2017 Q3	$1.07M	Hold	13,184	–	–	0.16%	95
2017 Q2	$933K	Hold	13,184	–	–	0.15%	95
2017 Q1	$895K	Hold	13,184	–	–	0.14%	97
2016 Q4	$944K	Hold	13,184	–	–	0.16%	97
2016 Q3	$1.04M	Hold	13,184	–	–	0.18%	87
2016 Q2	$1.1M	Hold	13,184	–	–	0.2%	83
2016 Q1	$1.21M	Sell	13,184 -491	-4%	-$44.3K	0.23%	76
2015 Q4	$1.38M	Sell	13,675 -2,319	-14%	-$241K	0.26%	70
2015 Q3	$1.57M	Sell	15,994 -1,410	-8%	-$157K	0.31%	58
2015 Q2	$2.04M	Sell	17,404 -460	-3%	-$50.3K	0.37%	43
2015 Q1	$1.75M	Sell	17,864 -40	-0.2%	-$4.06K	0.32%	54
2014 Q4	$1.69M	Sell	17,904 -3,920	-18%	-$405K	0.32%	53
2014 Q3	$2.32M	Sell	21,824 -100	-0.5%	-$9.79K	0.41%	38
2014 Q2	$1.82M	Hold	21,924	–	–	0.35%	49
2014 Q1	$1.55M	Sell	21,924 -360	-2%	-$28.2K	0.31%	55
2013 Q4	$1.67M	Sell	22,284 -142	-0.6%	-$9.89K	0.33%	51
2013 Q3	$1.41M	Hold	22,426	–	–	0.31%	55
2013 Q2	$1.15M	Buy	+22,426	New	+$1.17M	0.27%	63

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Cohen Klingenstein's GILD Position: Q2 2026 in Review

Cohen Klingenstein held its Gilead Sciences (GILD) position steady in Q2 2026 at 20,700 shares worth $2.62M. The position accounts for 0.07% of the portfolio, ranked #108.

Cohen Klingenstein first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.4M in Q2 2020. 965 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Cohen Klingenstein held 20,700 shares of Gilead Sciences worth $2.62M as of Q2 2026.
Cohen Klingenstein left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.07% of Cohen Klingenstein's portfolio in Q2 2026, its #108 holding.
Cohen Klingenstein first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
Cohen Klingenstein's Gilead Sciences position peaked at $3.4M in Q2 2020.
965 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cohen Klingenstein's 13F filing for Q2 2026, filed 15 Jul 2026.